Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Prestige Consumer Healthcare Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 377 | 8 | 356 | −13 |
| Shares | 52.0M | 712.2K | 50.8M | −506.3K (−1.0%) |
| Value | $4.16B | $56.9M | $3.17B | −$926.4M (−22.6%) |
8 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (45)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (58)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
Not filed for Q3 2025 yet (8)
Institutions that held Prestige Consumer Healthcare Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Norges Bank | 524,077 | $41.8M |
| Congress Wealth Management LLC | 163,185 | $13.0M |
| J. W. Coons Advisors, LLC | 10,100 | $806.5K |
| Scott Marsh Financial, LLC | 8,116 | $648.1K |
| CIBC World Markets Corp | 6,098 | $486.9K |
| First Horizon Advisors, Inc. | 599 | $47.8K |
| Parkworth Wealth Management, Inc. | 2 | $160 |
| Financial Gravity Companies, Inc. | 1 | $80 |